0000883975 EX-FILING FEES 0000883975 2025-07-21 2025-07-21 0000883975 1 2025-07-21 2025-07-21 0000883975 2 2025-07-21 2025-07-21 0000883975 3 2025-07-21 2025-07-21 0000883975 4 2025-07-21 2025-07-21 0000883975 5 2025-07-21 2025-07-21 0000883975 6 2025-07-21 2025-07-21 0000883975 7 2025-07-21 2025-07-21 0000883975 8 2025-07-21 2025-07-21 0000883975 9 2025-07-21 2025-07-21 0000883975 10 2025-07-21 2025-07-21 0000883975 11 2025-07-21 2025-07-21 0000883975 12 2025-07-21 2025-07-21 0000883975 13 2025-07-21 2025-07-21 0000883975 14 2025-07-21 2025-07-21 0000883975 15 2025-07-21 2025-07-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

Exhibit 107

 

Calculation of Filing Fee Table

 

 Form S-8

(Form Type)

 

Microbot Medical Inc.

(Exact Name of Registrant as Specified in its Charter)

Previously Paid Amount 

Table 1: Newly Registered Securities

 

Security
Type
  Security
Class
Title
  Fee
Calculation
Rule
  Amount
Registered(1)
   Proposed
Maximum
Offering
Price
Per
Share
   Maximum
Aggregate
Offering
Price
   Fee
Rate
   Amount of
Registration
Fee
 
Equity (2)  Common Stock, par value $0.01 per share  Rule 457(c) and 457(h)   3,791,019   $2.49(3)  $9,439,637.30    0.00015310   $1,445.21 
Equity (4)  Common Stock, par value $.0.01 per share  Rule 457(h)   190,000   $8.48   $1,611,200    0.00015310   $246.67 
Equity (4)  Common Stock, par value $.0.01 per share  Rule 457(h)   145,000   $6.48   $939,600    0.00015310   $143.85 
Equity (4)  Common Stock, par value $.0.01 per share  Rule 457(h)   173,000   $3.73   $645,290    0.00015310   $98.79 
Equity (4)  Common Stock, par value $.0.01 per share  Rule 457(h)   115,000   $2.43   $279,450    0.00015310   $42.78 
Equity (4)  Common Stock, par value $.0.01 per share  Rule 457(h)   167,500   $1.2684   $212,457    0.00015310   $32.52 
Equity (4)  Common Stock, par value $.0.01 per share  Rule 457(h)   115,192   $1.25   $143,990    0.00015310   $22.04 
Equity (4)  Common Stock, par value $.0.01 per share  Rule 457(h)   361,875   $2.04   $738,225    0.00015310   $113.02 
Equity (4)  Common Stock, par value $.0.01 per share  Rule 457(h)   67,855   $7.00   $474,985    0.00015310   $72.72 
Equity (4)  Common Stock, par value $.0.01 per share  Rule 457(h)   83,185   $5.71   $474,986.35    0.00015310   $72.72 
Equity (4)  Common Stock, par value $.0.01 per share  Rule 457(h)   371,090   $1.28   $474,995.20    0.00015310   $72.72 
Equity (4)  Common Stock, par value $.0.01 per share  Rule 457(h)   70,000   $1.93   $135,100    0.00015310   $20.68 
Equity (4)  Common Stock, par value $.0.01 per share  Rule 457(h)   35,000   $3.48   $121,800    0.00015310   $18.65 
Equity (4)  Common Stock, par value $.0.01 per share  Rule 457(h)   10,000   $4.7973   $47,973    0.00015310   $7.34 
Equity (4)  Common Stock, par value $.0.01 per share  Rule 457(h)   25,000   $1.29   $32,250    0.00015310   $4.94 
Total Offering Amounts            $15,771,938.85        $2,414.65 
Total Fee Offsets                      $- 
Net Fee Due                      $2,414.65 

 

(1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement also covers any shares of Microbot Medical Inc. (the “Registrant”) common stock that become issuable under the Microbot Medical Inc. 2020 Omnibus Performance Award Plan (“Plan”) by reason of any stock split, recapitalization, stock dividend or other similar transaction or capital adjustment.
   
(2) Represents the registration of 3,791,019 shares of common stock available to be issued under the Plan.
   
(3) Estimated solely for the purposes of calculating the registration fee pursuant to Rule 457(c) and Rule 457(h)(l) under the Securities Act, on the basis of the average of the high ($2.59) and low ($2.39) reported prices of the shares of Common Stock of the Registrant as reported by the Nasdaq Capital Market on July 16, 2025, a date within five business days prior to the filing of this Registration Statement.
   
(4) Represents the resale of up to 2,009,697 shares of common stock by certain officers and directors of the Registrant that consist of options that were previously issued and that have vested or will vest pursuant to the Plan.